A 58-year-old man with a 20-year history of controlled hypertension (on amlodipine) and type 2 diabetes mellitus (on metformin) presents for elective laparoscopic cholecystectomy. On pre-anesthetic evaluation, his blood pressure is 138/88 mmHg, heart rate 76 bpm, and blood glucose 145 mg/dL. Cardiac examination is normal, and he has no dyspnea on exertion. What is the most appropriate next step in management?

Explanation

## ASA Physical Status Classification — Application ### Clinical Context This patient has mild, controlled systemic disease (hypertension and diabetes) with no evidence of end-organ dysfunction or acute decompensation. He is asymptomatic, has normal cardiac examination, and is undergoing a low-to-moderate risk elective procedure. ### ASA Classification Framework | ASA Class | Definition | Examples | Perioperative Risk | |-----------|-----------|----------|-------------------| | **ASA I** | Healthy, no systemic disease | Young, fit, no comorbidities | Minimal | | **ASA II** | Mild systemic disease, well-controlled | HTN, DM, obesity (no end-organ damage) | Low | | **ASA III** | Severe systemic disease, functional limitation | Poorly controlled HTN, DM with complications, CAD | Moderate | | **ASA IV** | Severe systemic disease, constant threat to life | MI within 6 months, unstable angina, severe CHF | High | | **ASA V** | Moribund, unlikely to survive without surgery | Massive hemorrhage, sepsis, cardiac arrest | Very high | | **ASA VI** | Brain-dead, organ procurement | — | — | ### Key Point: **Controlled hypertension and diabetes alone do NOT mandate additional cardiac testing in asymptomatic patients with normal examination.** This patient meets ASA II criteria and does not require stress testing or echocardiography. ### High-Yield: ASA II classification is appropriate for patients with **mild, stable systemic disease without functional limitation**. The presence of controlled comorbidities does not automatically require advanced investigations—clinical judgment and risk stratification guide the decision. ### Clinical Pearl: The goal of pre-anesthetic evaluation is **risk stratification, not diagnosis of new disease**. Routine screening tests in asymptomatic, stable patients increase cost and delay surgery without improving outcomes. Selective testing is indicated only if history, examination, or planned procedure suggests increased risk. ### Next Step: Optimize perioperative management: - Continue home antihypertensive and antidiabetic medications perioperatively - Ensure adequate fasting and glucose control - Monitor blood pressure and glucose intraoperatively - Plan anesthetic technique appropriate for ASA II risk [cite:Stoelting's Anesthesia and Co-existing Disease 6e Ch 1]